21st.BIO A/S: Financial statements 2022
CVR: 41554908
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
21st.BIO A/S (CVR 41554908) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -21,930,501 and a net result of DKK -36,612,241. Equity in the 2022 report amounted to DKK 262,615,831. The solvency ratio was 79.7%. The company had 11 employees in the financial year.
- Gross Profit
- DKK -21,930,501
- Profit/Loss
- DKK -36,612,241
- Equity
- DKK 262,615,831
- Total Assets
- DKK 329,387,976
- Employees
- 11
Official annual report
Keep an eye on 21st.BIO A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of September 30, 2022, Claus Crone Fuglsang has joined the board of directors of 21st.BIO A/S.
As of September 30, 2022, Amy Louise Byrick has joined the board of directors of 21st.BIO A/S.
As of September 30, 2022, NOVOZYMES A/S is registered as an owner of 21st.BIO A/S with an ownership share of 33%.
As of September 30, 2022, Momentum Techinvest ApS is registered as an owner of 21st.BIO A/S with an ownership share of 5%.
As of August 10, 2022, Thorvald Uhrskov Ullum is registered as director of 21st.BIO A/S.
21st.BIO A/S has published its interim report for the period August 1, 2020 – December 31, 2021.
As of January 1, 2022, Per Falholt is registered as director of 21st.BIO A/S.
About 21st.BIO A/S
21st.BIO A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 2020. The company is registered under the industry Anden teknisk rådgivning. The company was previously named Copenhagen Bio Partners A/S. The management consists of Henrik Marcus Geertz-Hansen, Jose Arnau Martinez and Mikael Bechsgaard. The board consists of Anders Bendsen Spohr (chair), Claus Crone Fuglsang, Thomas Dal Stenfeldt Batchelor and Thomas Grotkjær. The company is owned by Novo Holdings A/S, NOVOZYMES A/S and Momentum Techinvest ApS. The company has 44 employees (2026). In 2025, the company reported a gross profit of DKK -15,518,420 and a net result of DKK -127,801,300 compared with DKK -41,660,123 the year before. Equity in the 2025 report amounted to DKK 202,530,839.